Literature DB >> 16547207

Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation.

A Nergårdh1, M Frick.   

Abstract

OBJECTIVE: To investigate the agreement between perceived heart rhythm and the ECG-registered heart rhythm, as well as between symptoms and the ECG after direct current (DC) cardioversion of atrial fibrillation (AF).
METHODS: Consecutive patients with symptomatic AF subjected to DC cardioversion were interviewed about perceived heart rhythm and symptoms one week after restoration of sinus rhythm (SR). An ECG was obtained after the interview. A chance-corrected measure of agreement was calculated by using Cohen's kappa test.
RESULTS: 356 patients were enrolled. One week after successful cardioversion 160 patients considered their rhythm to be regular and 222 ECGs showed SR. 130 patients considered their heart rhythm to be regular in agreement with ECG in SR (kappa = 0.34, 95% confidence interval (CI) 0.24 to 0.44), indicating a fair agreement. At the same time 59 patients perceived AF and 134 ECGs showed AF. Thirty eight patients perceived AF, in agreement with AF found on their ECG (kappa = 0.13, 95% CI 0.02 to 0.25), a poor agreement. 141 of 356 patients reported improvement of symptoms in agreement with SR on their ECG (kappa = 0.26, 95% CI 0.15 to 0.36), indicating fair agreement. Perceived SR and improvement of symptoms were strongly associated (n = 129; p < 0.001).
CONCLUSION: Agreement between perceived heart rhythm and ECG, as well as between improvement of symptoms and SR recorded on the ECG, is no more than poor to fair after successful cardioversion of patients with persistent AF. The association between perceived SR and improvement of symptoms is strong. These findings support the need for objective criteria to select patients who would benefit most from rhythm control. They also support the need for further studies on quality of life of patients with AF, with due attention paid to patients' perception of their cardiac rhythm.

Entities:  

Mesh:

Year:  2006        PMID: 16547207      PMCID: PMC1861159          DOI: 10.1136/hrt.2005.082156

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  21 in total

1.  Quality of life in patients with silent atrial fibrillation.

Authors:  I Savelieva; M Paquette; P Dorian; B Lüderitz; A J Camm
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

2.  Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics.

Authors:  V Frykman; M Frick; M Jensen-Urstad; J Ostergren; M Rosenqvist
Journal:  J Intern Med       Date:  2001-11       Impact factor: 8.989

3.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

Review 4.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

5.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

Authors:  P Dorian; W Jung; D Newman; M Paquette; K Wood; G M Ayers; J Camm; M Akhtar; B Luderitz
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

6.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

7.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

8.  Time to recover from atrial hormonal, mechanical, and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation.

Authors:  M Nishino; S Hoshida; J Tanouchi; T Ito; J Kato; K Iwai; H Tanahashi; M Hori; Y Yamada; T Kamada
Journal:  Am J Cardiol       Date:  2000-06-15       Impact factor: 2.778

9.  Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation.

Authors:  Beata Wozakowska-Kapłon; Grzegorz Opolski
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

10.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

Authors:  Jörg Carlsson; Sinisa Miketic; Jürgen Windeler; Alessandro Cuneo; Sebastian Haun; Stefan Micus; Sabine Walter; Ulrich Tebbe
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

View more
  5 in total

1.  Rhythm control strategies for "symptomatic" persistent atrial fibrillation: is achieving sinus rhythm enough?

Authors:  T R Betts
Journal:  Heart       Date:  2006-04-27       Impact factor: 5.994

2.  Relevance of Monitoring Atrial Fibrillation in Clinical Practice.

Authors:  Thorsten Lewalter; Giuseppe Boriani
Journal:  Arrhythm Electrophysiol Rev       Date:  2012-09

3.  Validity and reliability of a new, short symptom rating scale in patients with persistent atrial fibrillation.

Authors:  Marie Härdén; Britta Nyström; Károly Kulich; Jonas Carlsson; Ann Bengtson; Nils Edvardsson
Journal:  Health Qual Life Outcomes       Date:  2009-07-15       Impact factor: 3.186

4.  Design of the Pacemaker REmote Follow-up Evaluation and Review (PREFER) trial to assess the clinical value of the remote pacemaker interrogation in the management of pacemaker patients.

Authors:  Jane Chen; Bruce L Wilkoff; Wassim Choucair; Todd J Cohen; George H Crossley; W Ben Johnson; Luc R Mongeon; Gerald A Serwer; Lou Sherfesee
Journal:  Trials       Date:  2008-04-03       Impact factor: 2.279

5.  Randomised clinical trial of cryoballoon versus irrigated radio frequency catheter ablation for atrial fibrillation-the effect of double short versus standard exposure cryoablation duration during pulmonary vein isolation (CIRCA-DOSE): methods and rationale.

Authors:  Jason G Andrade; Marc W Deyell; Mariano Badra; Jean Champagne; Marc Dubuc; Peter Leong-Sit; Laurent Macle; Paul Novak; Jean-Francois Roux; John Sapp; Anthony Tang; Atul Verma; George A Wells; Paul Khairy
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.